e-learning
resources
Virtual 2020
Pre-Congress Content
Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic characteristics in chronic hypersensitivity pneumonitis.
D. Neville (Portsmouth (Hampshire), United Kingdom), T. Jones (Portsmouth (Hampshire), United Kingdom), A. Tiwari (Birmingham, United Kingdom), V. Titmuss (Portsmouth, United Kingdom), A. Donaldson (Portsmouth, United Kingdom), K. Babu (Portsmouth, United Kingdom)
Source:
Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Session:
Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Session type:
E-poster session
Number:
3539
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Neville (Portsmouth (Hampshire), United Kingdom), T. Jones (Portsmouth (Hampshire), United Kingdom), A. Tiwari (Birmingham, United Kingdom), V. Titmuss (Portsmouth, United Kingdom), A. Donaldson (Portsmouth, United Kingdom), K. Babu (Portsmouth, United Kingdom). Prognostic characteristics in chronic hypersensitivity pneumonitis.. 3539
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Related content which might interest you:
Prognostic factors in chronic hypersensitivity pneumonitis
Source: Eur Respir Rev, 29 (156) 190167; 10.1183/16000617.0167-2019
Year: 2020
Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Year: 2020
Impact Prognostic impact of comorbidities in patients with chronic Hypersensitivity Pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Prognostic factors in severe eosinophilic asthma
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Factors predicting response to azathioprine in chronic hypersensitivity pneumonitis – the importance of BAL lymphocytosis
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
Criteria for PF-ILD in a cohort of patients with chronic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006
Squeaks in hypersensitivity pneumonitis: prevalence and clinical correlates
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019
Importance of unrecognised exposure to avian antigen in chronic bird-related hypersensitivity pneumonitis
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Diagnosis, course and management of hypersensitivity pneumonitis
Source: Eur Respir Rev, 31 (163) 210169; 10.1183/16000617.0169-2021
Year: 2022
Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis
Source: ERJ Open Res, 4 (3) 00043-2018; 10.1183/23120541.00043-2018
Year: 2018
Clinical features of acute exacerbation in chronic birdfancier‘s lung
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006
Clinical features and predictive factors for acute exacerbation of idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Year: 2007
Prognostic factors in severe eosinophilic asthma in children
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018
Clinical utility of CCL15 as a prognostic biomarker for hypersensitivity pneumonitis
Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new?
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept